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HIV Positive Patients In Intensive Care – A Retrospective Chart review 
Thesis Abstract  
 
Background:   
The indications for and outcomes of intensive care unit (ICU) admission of HIV-infected 
patients in resource-poor settings like Sub-Saharan Africa are unknown. 
 
Methods:   
We reviewed case records of HIV-infected patients admitted to the medical and surgical 
ICUs at Groote Schuur Hospital, South Africa from 1 January 2012 to 31 December 2012. 
HIV infection was defined as two positive antibody tests.  
 
Results:   
Seventy seven HIV-infected patients were admitted to ICU, 2 were younger than 18 years 
and were excluded from the final analysis. HIV infection was newly diagnosed in 37.3% of 
the patients admitted during this period. HIV-positive patients had a mean (± standard 
deviation) CD4 count of 293.9×106/L ± 247.2×106/L. Respiratory illness accounted for 
30.7% of ICU admissions, community-acquired pneumonia was responsible for the majority 
of the respiratory cases. ICU and hospital mortality was 25.3% and 34.7% respectively. 
Predictors of ICU mortality included an APACHE ΙΙ score >13 (Odds Ratio {OR}, 1.4; 95% 
confidence interval {CI} 1.1-1.7; p value 0.015), receipt of renal replacement therapy (OR, 
2.2; 95% CI 1.2-4.1; P 0.018) and receipt of inotropes (OR 2.3; 95% CI 1.6-3.4; P <0.001). 
Predictors of hospital mortality were severe sepsis on admission (OR, 2.8; 95% CI 0.9-9.1;p 
0.07), receipt of renal replacement therapy (OR, 1.9; 95% CI 1.0-3.6; p 0.056), receipt of 
inotropic support (OR, 2.0; 95% CI 1.4-3.2; p 0.001). Use of highly active antiretroviral 
therapy, CD4 count, detectable HIV viral load and the diagnoses at ICU admission did not 
predict ICU or hospital mortality. 
 
Conclusion 
Respiratory illnesses remain the main indication for ICU in HIV infected patients. HIV is 
diagnosed late with patients presenting in dire straits. Receipt of HAART, CD4 count and 
the diagnoses at ICU admission are not predictors of ICU or hospital mortality, but rather the 
severity of illness as indicated by a high APACHE ΙΙ score, multiple organ dysfunction 





1.1 Chapter 1 
HIV sero-positive adults In Intensive Care Unit  – Literature review  
 
1.1.1 Introduction  
 
Acquired Immunodeficiency syndrome (AIDS) is the most severe manifestation of a clinical 
spectrum of illness caused by infection with Human Immunodeficiency Virus (HIV). AIDS 
is defined by the development of serious opportunistic infections, neoplasms, or other life 
threatening manifestations resulting from profound progressive HIV-induced 
immunosuppression. AIDS was first recognized in mid 1981, when unusual clusters of 
Pneumocystis jirovecii pneumonia and Kaposi’s sarcoma were reported in young, previously 
healthy homosexual man in New York City, Los Angeles and San Francisco (1). Two years 
after the first reports of AIDS, a retrovirus, Human Immunodeficiency Virus was isolated 
from the persons with AIDS and associated conditions (2). In 1985, serologic tests to detect 
evidence of infection with HIV were developed to identify those infected with the virus and 
to protect blood products (1).  
Today, HIV remains a major public health burden, with an estimated 35.3 million people 
infected globally. Sub-Saharan Africa bears the brunt with 25 million HIV-infected people 
living in the region (3). The advent of antiretroviral therapy (ART) has changed the natural 
history of HIV/AIDS with a reported decline in mortality from 24.5 per 100 person-years in 
1995 to 8.9 per 100 person-years in 1997 (4). Despite the good evidence of the role of 
antiretroviral therapy in decreasing morbidity and mortality in HIV/AIDS patients, most 
people living with HIV do not have access to ART. Globally, only 9.7 million people were 
estimated to be receiving ART in 2012 (5). The vast majority of HIV-infected people present 
with advanced disease characterized by severe opportunistic infections (6). Large numbers 
are unaware of their HIV status and present for the first time with severe illnesses requiring 
intensive care (7). Between 7 and 12% of HIV-positive patients admitted to hospital are 
treated in an Intensive Care Unit (ICU) (8, 9). 
 
This literature review describes published evidence of the admission of patients with 
HIV/AIDS to an ICU. The attention is focused on the indications for admission to intensive 
care, the outcomes of the patients that were admitted to intensive care, and the changes in 






1.1.2 Methods  
 
A literature search from 1981 to 2013 was performed using MEDLINE. Papers containing 
the terms Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome and 
Intensive Care Unit or critical care were identified and assessed to determine whether they 
met the inclusion criteria for the review. Inclusion criteria were: 
• HIV-positive patients admitted to Intensive Care Unit 
• Adults  
• Full text available 
• English language 
 
The reference list of papers that satisfied the inclusion criteria were scrutinized to identify 
papers not identified in the original search process. 
 
1.1.3 Results  
 
1980-1995 (Table 1) 
 
Pneumocystis jirovecii (carinii) pneumonia (PJP) represented the most common indication 
for ICU admission and mechanical ventilation in patients with HIV/AIDS during this period, 
accounting for up to 72% of HIV/AIDS patients admitted to ICU (10). The use of 
mechanical ventilation in this patient population varied from 33% in 1983 and 1984 
combined, 0% in 1987, 15% in 1989 and 1% in 1990 (11). This was mostly based on 
perceived futility of mechanical ventilation for PJP by both physicians and patients (12). 
Pneumocystis pneumonia was the most common pulmonary disorder in AIDS patients (13). 
Up to 30% of the patients with PJP had coexisting pulmonary infections. Patients with PJP 
requiring intubation and ventilation had a very poor prognosis with a patient mortality of up 
83% (14).  
 
Brenner et al. (14) evaluated 43 consecutive AIDS  patients with pulmonary symptoms and 
abnormal chest radiographs for PJP. No patients received corticosteroids. Thirteen of the  
patients died, severe abnormalities on initial chest radiographs and alveolar-arterial oxygen 
difference > 30 mm Hg were associated with higher mortality during the period of treatment 





El-Sadr and Simberkoff (15) analysed records of 19 patients with pneumocystis pneumonia 
who required mechanical ventilation, mortality was 57%..  Most of the nonsurvivors had co-
infections which included Mycobacterium avian intracellulare and M. tuberculosis. The 
investigators did not comment on the treatment instituted and on whether the other infections 
were treated (15). 
 
Wachter et al (16) reviewed the medical records of AIDS patients admitted to the ICU for 
PJP from 1981 to 1985 (Era Ι) and 1986 to 1988 (Era ΙΙ). The in-hospital mortality rate in 
Era Ι was 86%, compared to 60% in Era ΙΙ; the major difference between the two time 
periods was that 74% of patients in Era ΙΙ received corticosteroids compared to only 5% in 
Era Ι. The l-year survival rate among Era II patients was 9%. Of the 6 Era I patients who 
survived ICU hospitalization, 5 died within 1 year of discharge (16). 
 
In an attempt to identify methods of assessing prognosis in AIDS patients admitted to ICU 
for PJP-induced acute respiratory failure, Mantaner and coworkers assessed 52 ICU 
admissions of 51 AIDS patients (17). Forty-seven patients required mechanical ventilation, 
34 (72%) died in ICU, 2 more died before hospital discharge. Increased multisystem organ 
failure (MSOF) score was strongly associated with death from acute respiratory failure due 
to PJP despite ICU admission. The Acute Lung Injury (ALI) score, and APACHE II were 
not significantly associated with mortality. 85% of the patients had received adjuvant 
corticosteroids (17). 
 
Peruzzi et al (18) retrospectively reviewed 29 AIDS patients with PJP admitted to the 
medical ICU for concurrent lung infections. The incidence of concurrent bacterial lung 
infection was 7%, compared to 17% in a control group. Overall, 20 of the 29 patients with 
AIDS and PJP died, however concurrent bacterial infections did not have a significant 
impact on mortality (18). 
 
The high mortality rate for PJP with respiratory failure continued through the late 1980s to 
the early 1990s. Staikowsky el al (19) retrospectively reviewed records of 33 patients with 
AIDS and PJP with acute respiratory failure requiring mechanical ventilation. All the 
patients were appropriately treated with anti-pneumocystis therapy and corticosteroids. They 
demonstrated an 81.9% mortality rate with no difference in prognostic factors between the 
survivors and the non-survivors. However, this study also had a very high ventilator 
complication rate with 20 cases of pneumothorax; the role of these complications on the 





Late in the first decade of the HIV/AIDS epidemic, Hawley et al (20) reported a decline in 
the frequency of acute respiratory failure secondary to PJP. In a retrospective chart review of 
456 episodes of PJP between 1987 and 1991, acute respiratory failure developed in 47 
patients (9%). Twenty-seven required mechanical ventilation, of whom 24 died. Despite the 
decreasing frequency of acute respiratory failure in AIDS-related PJP, intensive care 
outcomes remained dismal.  The lower frequency of both acute respiratory failure and need 
for mechanical ventilation were attributed to the early use of corticosteroids (20).  
 
Torres and colleagues (21) assessed 42 HIV/AIDS patients admitted to a respiratory ICU 
because of acute respiratory failure and lung infiltrates. Twenty-eight (67%) had PJP, 14 
(31%) of the patients had polymicrobial infection, 7 had both.  The mortality rate was higher 
in PJP patients (18/28 versus 5/14), in patients that required mechanical ventilation, and 
where there more than 3 days between hospital and ICU admission (21). Nineteen (45%) 
patients were discharged alive from the ICU. The median survival times were 49 days for the 
PJP population versus 154 days for other etiologies of respiratory failure (21). 
 
De Palo et al (22) studied 65 consecutive patients with HIV admitted to a medical ICU to 
determine the outcome of ICU for different illnesses in this patient population. Respiratory 
failure accounted for 35 patients, 23 of which were secondary to PJP. Sixteen of the patients 
with PJP were mechanically ventilated, 81% of these died. Mechanical ventilation was 
required in 23 with respiratory failure with a mortality rate of 79%.  These included bacterial 
pneumonia (6), pulmonary tuberculosis (3), ARDS (2), and pulmonary Kaposi's sarcoma (1). 
Other causes for admission included sepsis syndrome (10, 5 died), neurologic diseases (8, 3 
died), and dilated cardiomyopathy (4, 1 died). Overall mortality was 51% - low CD4 count, 
respiratory failure and need for mechanical ventilation were associated with a higher 
mortality rate (22).  
 
In a multicenter prospective study, Rosen et al (23) followed up 1,130 adult patients with 
HIV to determine ICU admission rates and diagnosis. After 4,298 person-years of follow-up 
there were 1,361 hospital admissions and 68 ICU admissions. Twenty-four (35%) of the ICU 
admissions were for pulmonary diseases, 11 had PJP of whom 6 died.  Twenty-five of the 
patients admitted to ICU died, mortality was higher in patients with pulmonary diseases 
(67% versus 20%). 16 of 28 patients requiring mechanical ventilation died.  However, 
patients with previous AIDS-defining illnesses were excluded, which might account for the 





To determine predictors of short-term and long-term survival in HIV-infected patients 
admitted to ICU, Casalino et al (24) prospectively studied 354 HIV-infected patients 
admitted to their ICU. Two hundred and eighty patients had AIDS, 131 had a first AIDS-
defining illness as the reason for ICU admission. Respiratory illnesses represented the 
majority of cases (49.2%) followed by neurological illnesses (26.8%). PJP accounted for 
45% and bacterial pneumonia for 47% of admissions. Toxoplasma encephalitis was the 
leading neurological illness, being responsible for 16.6% of all HIV-related ICU admissions.   
The ICU mortality rate was 20.6%; respiratory illness mortality was 16.7%, neurological 
illness 23.2%, heart failure 25% and severe sepsis 38%. Mechanical ventilation, duration of 
mechanical ventilation, percent weight loss, and a higher SAPS Ι score were significantly 
associated with higher ICU mortality. These factors were also associated with a high hospital 
mortality rate of 39%. PJP represented a smaller proportion in this study compared to 
previous work, but a constant theme was maintained in which mechanical ventilation for PJP 
was associated with a higher mortality rate (40% versus 5.1%) (24). 
 
1995 – 2004 (Table 2) 
 
During this period, corticosteroids were generally used for PJP and ART was becoming 
more universally available.  The prevalence of PJP was lower, and ICU admission was 
generally for other opportunistic infections as well as incidental conditions. 
 
Gill et al (25) retrospectively studied 127 HIV-positive patients admitted to ICU in multiple 
centers in Britain. Of the 94 patients with an HIV diagnoses made prior to ICU admission, 
56 had a prior AIDS diagnosis and only 23 (24%) were on ART. Median CD4 count was 40.  
Respiratory support accounted for 54.1% of indications for ICU admission.  This cohort had 
an ICU mortality of 33% and a hospital mortality of 56%. Mechanical ventilation, CD4 
count < 100 cell/mL, previous AIDS diagnosis and PJP were associated with higher ICU and 
hospital mortality (25). 
 
Afessa and Green (9) prospectively observed 169 ICU admissions of 141 HIV-positive 
patients from April 1995 to March 1999. Thirty-eight of the 169 admissions were transferred 
from a medical or surgical ward, mortality was 47%; 131 were admitted from the emergency 
department with mortality 24%. Overall hospital mortality was 29.6%. Patients with CD4 
count > 200 had a lower mortality rate than those with a CD4 less than 200 (22.2% versus 
32.8%).  Respiratory failure was the most common reason for admission to ICU, with 




causes of pneumonia or for respiratory failure compared to other reasons for admission. 
Mechanical ventilation was required in 91 (54%) of all ICU admissions, hospital mortality 
rate was 48%.  There was no difference in mortality between those mechanically ventilated 
for a respiratory disorder and for non-respiratory disorders.  Development of ARDS was 
associated with a high mortality rate.  Systemic inflammatory response syndrome (SIRS) 
developed in 126 (75%), this was associated with a higher mortality (37% vs. 9%). Sepsis 
was the common cause of SIRS and the lungs were the major site of infection.  Severe sepsis 
and septic shock were associated with a high hospital mortality rate. Non-survivors in this 
study had a median of 4 organ failures compared to 1 in survivors (9). 
 
A chart review by Morris et al (26) examined 354 HIV-positive ICU admissions, average 
survival to hospital discharge was 71%. The use of ART increased with time, 4% of patients 
using ART in 1996 and 32.4% in 1999. Approximately 25% of patients were receiving ART 
at the time of ICU admission and these were more likely to survive to hospital discharge. 
ICU admission rates were unchanged in the ART era compared to the pre-ART era. 
Respiratory failure was the indication for ICU admission in 40% of the patients, and only 
10% of the patients were admitted for PJP. The majority of ICU admissions (63%) were non-
AIDS related. Survival was not related to CD4 count or HIV viral RNA level. ICU 
admission for non-AIDS related diagnoses and low APACHE II were highly predictive of 
improved hospital survival. Patients with AIDS-defining illnesses at the time of ICU 
admission had a poor survival, irrespective of whether they received ART at the time of ICU 
admission. PJP, mechanical ventilation and PJP-related pneumothorax were associated with 
a poor prognosis (26). 
 
In a single centre prospective study, Casalino and colleagues (27) investigated the impact of 
ART on ICU admission and survival patterns between January 1995 and June 1999. The 
ART era saw no decline in ICU admissions although there were fewer AIDS-related 
admissions. 40% of the patients were unaware of their HIV status before ICU admission, and 
more than 50% of patients were not receiving ART in both time periods. ICU mortality rate 
was 23%; ICU survivors were more likely to have been on ART, to have had no prior AIDS-
related illness, and to have a lower SAPS ΙΙ score.  One- and two-year survival after ICU 
discharge was 85.3% and 70.8% respectively. The use of ART, HIV stage, presence of AIDS 
prior to ICU admission and AIDS-related illness predicted long-term outcome (27).  
 
In another single centre prospective study, Narasimhan and others compared HIV-positive 
patients admitted to their ICU in 2001 (post-ART) with HIV-positive patients admitted to the 




admitted to ICU in the ART era had not received ART. PJP was present in 3% compared to 
34% pre-ART.  Most of the patients in the ART era were admitted for HIV-unrelated 
disorders. Survival to hospital discharge was higher in the ART era (71% vs. 49%).  Unlike 
the previous study, there was no association between the use of ART and survival. More 
patients received mechanical ventilation in the ART era but patient survival was improved 
(28). 
 
A similar lack of benefit from prior ART use in patients was shown by Benoit et al (29). 
More patients were on ART prior to ICU admission in the ART era compared to the pre-
ART era (119/236 vs. 5/189).  28% were newly diagnosed with HIV during ICU admission 
in the ART era compared to 19.6% in the pre-ART era. There was no ICU mortality 
difference between the two periods (25% versus 27%). Use of inotropes, mechanical 
ventilation, PJP, pneumothorax and higher SAPS ΙΙ predicted higher ICU mortality (29). 
 
In a retrospective chart review, Khouli et al (8) assessed the outcomes of critically ill HIV-
infected patients admitted to ICU in the era of ART. Over a 3-year period, there were 3902 
hospital admission of HIV-positive patients, 273 (7%) of these patients were admitted to 
ICU (8). Just under half (48%) of the ICU admissions were receiving ART prior to ICU 
admission. ICU and hospital mortality were 30% and 39% respectively. Use of ART prior to 
ICU admission was not associated with improved ICU mortality, hospital mortality or 
decreased length of hospital stay. Pulmonary diagnoses were the most common diagnoses at 
ICU admission (30%), with a mortality rate of 49% compared to 35% for non-pulmonary 
diagnoses. Sepsis and neurological diseases had mortality rates of 50% and 48% 
respectively. Thirty-four patients were admitted for PJP with a mortality of 53%, however 17 
of the 20 (85%) who required mechanical ventilation died (8). 
 
Palacios and colleagues (30) reported similar findings.  42% of patients were not aware of 
their HIV status prior to ICU admission; these patients were more immunocompromised and 
more likely to be admitted for PJP. Only 30% of the patients admitted to ICU in the ART era 
were receiving ART and 40% of these were admitted for HIV-related illnesses. There was an 
overall hospital mortality rate of 53% (30).  
 
Some authors have hypothesized that the mortality of HIV-positive patients admitted to ICU 
may be decreasing irrespective of the use of ART. Miller et al (31) retrospectively studied 59 
HIV-positive patients admitted to ICU for PJP between November 1990 and October 2005. 
More than half the patients were newly diagnosed with HIV during the index admission. 




prophylaxis prior to ICU admission. The authors report an ICU mortality rate of 44% and an 
overall mortality of 53%. Factors that were identified to be associated with a high mortality 
rate were mechanical ventilation and the development of a pneumothorax (31).  
 
HIV-positive individuals are at increased risk of respiratory illnesses, with 8 times the risk of 
bacterial pneumonia when compared to HIV-negative individuals (32). In one study, up to 
22% of HIV positive patients presented with acute lung injury requiring mechanical 
ventilation (33). Mechanical ventilation protocols have changed over time, with evidence 
from the Acute Respiratory Distress Syndrome Network (ARDSNet) advocating lung 
protective ventilation (34) - could this have affected the change in mortality in HIV positive 
patients with acute lung injury?  Davis and colleagues (33) assessed the effect of low tidal 
volume ventilation on mortality in HIV-positive patients with acute lung injury admitted to 
ICU; patient were divided into two time periods, pre-ARDSNet (before 2000) and post-
ARDSNet (after 2000). Of 685 HIV-positive patients admitted to ICU from 1996 to 2004, 
148 (22%) had acute lung injury, 74 admitted pre-ARDSNet and 74 post-ARDSNet. The 
aetiology of the acute lung injury in both groups were PJP (34%), non-Pneumocystis 
pneumonia (38%), sepsis (15%), and aspiration pneumonitis (7%). Lung protective 
ventilation did not significantly improve outcome (33). 
 
In a study by Barbier and coworkers (35) to determine the aetiology of acute respiratory 
failure in HIV-infected patients admitted to an ICU,  HIV-infected patients accounted for 5% 
of all ICU admissions; 147 (54.6%) were admitted with acute respiratory failure.  Bacterial 
pneumonia was most common (50.3%), followed by PJP (35.4%).  Two-thirds of the 
patients with PJP were newly diagnosed with HIV infection. 22% of patients in this cohort 
had two or more causes of acute respiratory failure; bacterial pneumonia was present with 
PJP in 9 and other opportunistic infections in 8 patients. Overall mortality was 19.7%.  
Factors associated with increased mortality were invasive mechanical ventilation, use of 
vasopressors, increased time from hospital admission to ICU transfer and increasing number 
of causes of acute respiratory failure. Of note, the CD4 count, HIV viral load, and use of 
ART did not predict mortality (35). 
 
In study by Boonsarngsuk et al, HIV-associated PJP with acute respiratory failure had a 
higher mortality rate in the first 7 days of ICU treatment, when compared to non-HIV 
associated PJP (14% vs. 0%), and the overall mortality was higher in the HIV-associated 
Pneumocystis group (36).  
 




admissions in HIV-infected patients, PJP was the most frequent cause of respiratory failure 
(28%).  In this study, the use of ART was not protective against respiratory failure, with 40% 
of patients with respiratory failure being on ART, and 42% not on ART. Sepsis was the 
second most common indication for ICU admission.  The incidence of respiratory failure as 
the cause of ICU admission decreased 52% to 34% between 2000 and 2004. PJP had also 
decreased from 24% to 9%. Poor outcomes were associated with mechanical ventilation, 
respiratory failure as the ICU admission diagnosis and PJP. Higher serum albumin and low 
APACHE II score were associated with survival to hospital discharge (37). 
 
In a retrospective study by Dickson et al (38), 102 HIV-positive patients were admitted; 48% 
had lower respiratory tract infection, 14% had a neurological illness. HIV-related diagnoses 
accounted for 67% of ICU admissions; these patients were more immunosuppressed with 
lower CD4 counts, and less likely to be on ART but had similar APACHE ΙΙ, identical need 
for mechanical ventilation and a similar rate of survival to ICU and hospital discharge when 
compared to those admitted for non-HIV-related diagnoses.  Only 37% of patients were on 
ART on ICU admission, but this did not affect outcome.  HIV-infected patients had similar 
rates of ICU and hospital survival compared to general medical patients. 30% of patients had 
a new diagnosis of HIV; these patients had a lower CD4 count and were more likely to 
present with PJP (38).  
 
There are few studies that report outcomes of HIV-infected patients admitted to ICU from 
developing or low income countries. A study from Mexico by Vargas-Infante and coworkers 
(39), reviewed ICU admissions of HIV-positive  patients from 1985 to 2006. Most patients 
in this study had AIDS (88%) and 31% of the patients were newly diagnosed with HIV. ICU 
admission was for mechanical ventilation in 77% and septic shock in 23%. ICU outcomes 
improved with the advent of ART, 28% of patients received ART in this study.  Septic shock 
and an APACHE ΙΙ score greater than 13 were associated with death in ICU (39). Similarly, 
in a study from Brazil by Croda et al (40), 278 HIV-infected patients admitted to ICU were 
retrospectively reviewed; 38% of the patients were newly diagnosed with HIV at the time of 
ICU admission, with 80.6% presenting with an AIDS-defining illness and a low CD4 count. 
Respiratory failure (33.1%) and sepsis (31.3%) were the most common indications for ICU 
admission. The majority of patients required mechanical ventilation (75.2%) and the use of 
vasopressors (61%). The ICU mortality rate was 55.4%, and the 6-month mortality rate was 
69.4%. Factors associated with poor prognosis were identified as sepsis as the main 
indication for ICU admission, APACHE ΙΙ > 19, serum albumin <20, mechanical ventilation 
within the first 24 hours of ICU admission.  The use of ART prior to ICU admission was not 





2005- 2013 (Table 3) 
 
This period is typified by widespread ART use, with more frequent admission for non-HIV-
related causes, but also admissions for complications of and resistance to ART.  A 
considerable number of ICU admissions were still for individuals who were unaware that 
they had HIV infection. 
 
In a study by Mrus and colleagues (41), HIV/AIDS accounted for 10.3% of severe sepsis 
cases admitted to hospital.  Patients with severe sepsis and HIV/AIDS were less likely to be 
admitted to ICU compared to those without HIV/AIDS, although those with HIV/AIDS had 
a higher mortality (41, 42). In their cohort of 88 HIV-infected patients admitted to ICU, 
Japiassu et al (42) demonstrated that severe sepsis at ICU admission or during ICU stay 
occurs in 50% of patients. Ward stay prior to ICU admission was associated with increased 
risk for sepsis, although CD4 count was not a risk factor. The lungs were the major source of 
sepsis (52%), followed by bacteraemia and venous catheter-related infections, representing 
38% and 7% respectively of all sources of sepsis. The majority of infections were 
nosocomial. In this study, there was a 49% in-hospital mortality rate; the presence of sepsis 
increased the risk of 28 day mortality by 4 times and the 6 month mortality by 3 times (42). 
 
Greenberg et al (43) showed that a majority of infections in HIV infected patients requiring 
ICU for severe sepsis were nosocomial or health care-associated, followed by AIDS-related 
infections. Patients with nosocomial and AIDS-related infections had lower CD4 counts and 
were less likely to be receiving ART. In this cohort, the respiratory tract was the major site 
of infection followed by blood stream infections.  The in-hospital mortality rate was 42%; 
death was associated with a higher APACHE ΙΙ and SOFA score, need for mechanical 
ventilation and vasopressor support (43). 
 
Chaing et al (44) retrospectively studied the aetiologic and prognostic factors of ICU 
admission in HIV-infected patients. In this study, respiratory failure was responsible for 
44.4% of ICU admissions and sepsis for 33.3%.  ICU mortality was 37% and hospital 
mortality was 48.9%; predictors of hospital mortality were a low CD4 count, admission 
diagnosis of sepsis and an interval of more than 24 hours between hospital admission and 
ICU transfers (44). 
 
The advent of ART ushered a new era in the management of HIV-positive patients, with 




colleagues (45) studied the survival of HIV-infected patients admitted to ICU in the era of 
ART; Respiratory illnesses remained the major condition requiring ICU admission with ICU 
and hospital survival of 74% and 58% respectively. Acute lung injury was present in 79% of 
those with respiratory illness; PJP and bacterial pneumonia were the major causes of acute 
lung injury. Respiratory illness requiring mechanical ventilation were associated with poor 
outcomes, with ICU and hospital survival of 66% and 62% respectively, compared to 93% 
and 82% for patients with respiratory illness not requiring mechanical ventilation. Just more 
than half (51%) of the patients in this cohort had an HIV-related admission, this group had 
ICU and hospital survival of 73% and 70% respectively, significantly lower than the group 
with non-HIV-related ICU admissions. 55 % of patients were receiving ART at the time of 
ICU admission; the use of ART was associated with a trend to higher ICU survival and 
significantly higher hospital survival, the APACHE ΙΙ score was similar in the two groups. 
Forty-two (22%) patients were newly diagnosed with HIV during the index admission, half 
of these patients had PJP. 
 
Van Lelyveld et al studied the short term and long term outcomes of HIV-infected patients in 
the ART era (46); 52% of patients in this cohort were admitted to ICU for an AIDS-related 
diagnosis. Only 36% were receiving ART at the time of ICU admission. Overall ICU and 
hospital mortality were 37% and 50% respectively, with a decrease in both ICU and hospital 
mortality in the ART era.  This study also highlighted a 1 year and 5 year mortality of 53% 
and 68% respectively in the ART era; this was a significant improvement from 71% and 
87% in the pre-ART era. Paradoxically, the group receiving ART had a higher ICU, hospital, 
1-year and 5-year mortality compared to the group not on ART. The ART era also ushered in 
improved outcomes in patients with PJP. Older age, APACHE ΙΙ > 20 and use of mechanical 
ventilation were predictors of poor outcomes (46). In contrast, Amancio et al (47) reported 
ICU and hospital mortality of 46% and 68% respectively and 2 year survival of 38%. Of 
note in Amancio’s cohort, 56% of patients were diagnosed with HIV within a year of 
admission to ICU and 92% of the patients were admitted with an AIDS-defining condition 
(47). In a French study by Morquin et al (48), HIV infected patients admitted to ICU had an 
ICU mortality of 36.7% but only 34.7% were alive at one year post-ICU discharge. ICU 
mortality was associated with the use of vasopressors, use of mechanical ventilation and 
higher APACHE ΙΙ and SAPS ΙΙ scores. CD4 count, HIV diagnosis, HIV viral load, the use 








The African perspective  
 
Bhagwanjee and colleagues reported no statistically significant deference in ICU mortality  
(29% vs. 24%; odds ratio 1.45; 95% confidence interval 0.75-2.80) and hospital mortality 
(3% vs.6%; odds ratio not calculated) for HIV infected patients compared to HIV uninfected 
patients admitted to a Durban Tertiary hospital in South Africa (49). This study was limited 
by the small number of HIV infected patients studied (52), the inclusion of pediatric patients 
(4% of the HIV infected patients) and the absence of the diagnoses at admission. HIV 
infected patients suffered more ICU complications but this did not affect mortality.  In a 
prospective study by Edge and collogues 5% (33/661) of patients tested for HIV admitted to 
the adult burns unit were HIV infected (50). Edge and colleagues reported a Hospital 
mortality rate of 27%, this was comparable to age and sex matched HIV uninfected control 
group (24%). There was no report on prior use of ART, opportunistic infection prophylaxis 
and the stage of HIV infection by CD4 count or clinically. The study by Edge and colleagues 
is a tertiary care unit study (Tygerburg Hospital, Cape Town), does not reflect outcomes at 
other levels of care in the same country.  
 
In a South African tertiary care unit (Groote Schuur, Cape Town), Arendse and collogues 
reported a 41% (48/117) hospital mortality rate in HIV infected patients requiring 
haemodialysis for acute kidney injury (51). A serum creatinine more than 1230 µmol/l, HIV 
associated nephropathy and other causes of acute kidney injury other than acute tubular 
necrosis were the predictors of mortality. The authers did not report whether the patients 
received care in ICU or not. Patients that did not receive haemodialysis where exclude.   
 
HIV infected patients accounted for 8.4% of ICU patients with Acinetobacter baumannii 
infection or colonization in a retrospective study by Ntusi and colleagues (52). These 
patients where more likely to have lower CD4 counts, higher APACHE ΙΙ and multiple organ 
dysfunctions syndrome. These variables reflect severity of illness rather than HIV specific 
findings.  The authors did not report on the mortality of the HIV infected patients in this 
study.  
 
African studies of HIV infected adults in ICU are limited by few patients numbers studied, 
they are mostly done in tertiary care centers and do not reflect the standard of care in rural 
and semi urban areas where the standard of ICU is less than ideal.  
 







Progress in the management of HIV and its manifestations has been gradual. There has been 
a decrease in ICU mortality of HIV infected patients over time. These improvements are 
attributed to the advent of ART, improved ICU care, decreased incidence of PJP in ICU and 
improved diagnostic strategies and use of prophylaxis against opportunistic infection in the 
HIV infected patient population.  
 
This review demonstrates the paucity of data from the developing world, where access to 
ART, ICU and prophylaxis against opportunistic infection like PJP is limited. Furthermore, 
there is very limited data on long-term outcomes and functional status beyond the ICU and 
hospital discharge. There is a need for high quality research from developing world further 
illuminate our understanding of the relationship between HIV and ICU that is deeply 


























1.1.4 Tables  
1.1.4.1.1 Table 1: Summary of studies from1981 to 1995 





Patients that  
Died in hospital (%) 
Brenner et al., 1987 
(14) 




Retrospective  1982- 1986 19 11(57%) 
Wachter et al., 1991 
(16) 
Retrospective 1981-1985 42 36 (86%) 
  1986-1988 35 21 (60%) 
Montaner et al., 
1992 (17) 
Observational 1985- 1991 51 37(72%) 
Peruzzi et al., 1992 
(18) 
Retrospective  1985-1989 29 20(69%) 
Staikowsky et al. 
1992 (19) 
Retrospective 1987-1992 33 27 (81.9%) 
Hawley et al. 1994 
(20) 
Retrospective  1987- 1991 27 25 (92.5%) 
Torres et al. 1995 
(21) 
Prospective  1985 - 1992 42 23 (55%) 
De Palo et al. 1995 
(22) 
Observational  1991-1992 65 33 (51%) 
Rosen et al. 1997 
(23) 
Prospective  1988-1994 63 25 (40%) 
Casalino et al. 1998 
(24) 




























Author  Type of Study Study Period  Number of 
Patients  
Patients that  
Died in hospital 
(%) 
Gill et al. 1999 
(25) 
Retrospective  1993-1997 127 74 (56%) 
Afessa and Green 
.2000 (9) 
Observational  1995-1999 141 (169 ICU 
admissions) 
50 (29.6%) 
Morris et al.2002 
(26) 
Retrospective  1996 -1999 295  29% 
Casalimo et 
al.2004 (27) 
Prospective 1995-1999 426 98 (23%) * 
Narasimhan et al. 
2004 (28) 
Prospective  2001  53 (63 ICU 
admissions) 
 18 (29%) 
Benoit et al. 2004 
(29) 
Observational  1995-1996 pre-HAART 
era 







Khouli et al. 2005 
(8) 
Retrospective  1997-1999 259 102 (39%) 
Palacios et al 
2006 (30) 
Retrospective  1990-2003 66 35(53%) 
Miller et al. 2006 
(31) 
Retrospective  1990-2005 59 32(53%) 
Dickson et al 
2007 (38) 
Retrospective  1999-2005 102 31(32%) 
Vargas-Infante et 
al 2007 (39) 






14 (87%) * 
15 (71%) 
23(43%) 
Davis et al 2008 
(33) 






Barbier et al 2009 
(35) 









Croda et al 2009 
(40) 
 1996-2006 278 (55.4%)* 























1.1.4.1.3 Table 3: Summary of studies from 2005 to 2013: * denotes ICU mortality. 
Author  Study type  Study period  Number of 
patients 
Patients that 
died in hospital  
(%) 
Japiassu et al 
2010 (42) 
Prospective  2006-2008 88 43(49%) 
Chiang et al 2011 
(44) 
Retrospective  2001-2010 135 66(48.9%) 
Yoon et al 2011 
(53) 
Retrospective  2005-2008 177 60(34%) 
Adlakha et al 
2011 (45) 
Retrospective  1999-2009  192 58(30%) 
Van lelyveld et al 
2011 (46) 






Amancio et al 
2012(47) 
Retrospective  2006 125 85(68%) 
Morquin et al 
2012 (48) 
Retrospective  1997-2008 98 37(36.7%)* 
 
1.1.4.1.4 Table 4: Summary of African studies: *denotes ICU mortality.  
Author  Study type Time period Number of 
patients  
Patients that 
died in hospital 
(%) 
Bhagwanjee et al 
1997 (49) 
Prospective  1993 - 1994 52  15 (29%)# 
Edge et al 2001 (50) Prospective  1996 - 1999 32 9 (27%) 
Arendse et al 2011 
(51) 
Retrospective  2002 - 2007 117 48 (41%) 
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1.2.1 Abstract  
 
Background:   
The indications for and outcomes of intensive care unit (ICU) admission of HIV-infected 
patients in resource-poor settings like Sub-Saharan Africa are unknown. 
 
Methods:   
We reviewed case records of HIV-infected patients admitted to the medical and surgical 
ICUs at Groote Schuur Hospital, South Africa from 1 January 2012 to 31 December 2012. 
HIV infection was defined as two positive antibody tests.  
 
Results:   
Seventy seven HIV-infected patients were admitted to ICU, 2 were younger than 18 years 
and were excluded from the final analysis. HIV infection was newly diagnosed in 37.3% of 
the patients admitted during this period. HIV-positive patients had a mean (± standard 
deviation) CD4 count of 293.9×106/L ± 247.2×106/L. Respiratory illness accounted for 
30.7% of ICU admissions, community-acquired pneumonia was responsible for the majority 
of the respiratory cases. ICU and hospital mortality was 25.3% and 34.7% respectively. 
Predictors of ICU mortality included an APACHE ΙΙ score >13 (Odds Ratio {OR}, 1.4; 95% 
confidence interval {CI} 1.1-1.7; p value 0.015), receipt of renal replacement therapy (OR, 
2.2; 95% CI 1.2-4.1; P 0.018) and receipt of inotropes (OR 2.3; 95% CI 1.6-3.4; P <0.001). 
Predictors of hospital mortality were severe sepsis on admission (OR, 2.8; 95% CI 0.9-9.1;p 
0.07), receipt of renal replacement therapy (OR, 1.9; 95% CI 1.0-3.6; p 0.056), receipt of 
inotropic support (OR, 2.0; 95% CI 1.4-3.2; p 0.001). Use of highly active antiretroviral 
therapy, CD4 count, detectable HIV viral load and the diagnoses at ICU admission did not 
predict ICU or hospital mortality. 
 
Conclusion 
Respiratory illnesses remain the main indication for ICU in HIV infected patients. HIV is 
diagnosed late with patients presenting in dire straits. Receipt of HAART, CD4 count and 
the diagnoses at ICU admission are not predictors of ICU or hospital mortality, but rather the 
severity of illness as indicated by a high APACHE ΙΙ score, multiple organ dysfunction 








Human immunodeficiency virus /acquired immunodeficiency syndrome (HIV/ AIDS) is a 
major public health burden, with an estimated 35.3 million people infected globally(1). Sub-
Saharan Africa (SSA) bears the brunt of the pandemic, with 25 million HIV-infected people 
living in the region(1). The advent of highly active antiretroviral therapy (HAART) has 
changed the natural history of HIV/AIDS with a reported decline in mortality from 24.5 per 
100 person years in 1995 to 8.9 per 100 person years in 1997(2) and reportedly 2.1 per 100 
person years in 2010(3). Today HIV-infected patients in high-income countries are reported 
to have a life expectancy approaching that of the general population(4). Despite evidence of 
the role of HAART in decreasing morbidity and mortality in HIV infected patients, in 
resource-poor settings many people living with HIV do not have access to HAART or 
receive treatment late. Globally, only 9.7 million people were estimated to be receiving 
HAART in 2012(5). Many HIV-infected people present with serious illnesses that may 
require intensive care unit (ICU) admission(6), and a large proportion of these are unaware 
of their HIV status(7). Data from high-income countries suggests that 7 to 12% of HIV-
infected patients admitted to hospital are treated in ICU (8, 9). 
Historically, respiratory failure accounted for the majority of ICU admissions in the HIV-
infected patient population, with an associated mortality of approximately 70% (9, 10).  
However, contemporary evidence from high-income countries suggests that ICU outcomes 
are similar to those of HIV-uninfected patients and that the indications for ICU are mostly 
not related to opportunistic infections (OIs) (10, 11). 
 
ICU utilisation and outcome for HIV infected patients in poorly resourced settings, where 
access to both ICU and HAART is limited, have not been widely studied. With increasing 
HIV prevalence, and an unchanging (at times, decreasing) number of available ICU beds, it 
is imperative to know the profile and outcome of HIV infected patients requiring ICU 
admission in a resource-poor setting like South Africa.  
 
The objective of this study was to identify indications for ICU admission and determine 
factors associated with high ICU and hospital mortality in HIV infected admitted to ICU in 
resource-limited settings. This will help in determining the appropriateness of offering ICU 
care to HIV-infected patients and in the appropriate development of policies and planning 





1.2.3 Methods  
1.2.3.1.1 Study design and patient population 
 
The study was a retrospective folder review conducted from 1 January 2012 to 31 December 
2012 in the medical and surgical ICUs at Groote Schuur Hospital (GSH) in Cape Town. 
GSH is a tertiary hospital affiliated to the University of Cape Town (UCT), and is a 867-bed 
institution with 16 general medicine and general surgery adult ICU beds (excluding the 
coronary care unit, neurosurgical ICU and the cardiothoracic ICUs). The study was carried 
out with the approval of GSH and UCT Human Subjects Research Ethics Committee. The 
need for obtaining informed consent was waived as this was a retrospective study, and no 
identifying details would be included.  
Patients were enrolled in the study if they were older than 18 years of age at the time of ICU 
admission, known to be HIV infected or were newly diagnosed with HIV in the index 
admission.  
Ward admission books and CLINICOM (a health information system including demographic 
and clinical patient data and providing a single electronic patient record that is accessible 
throughout the Western Cape province of South Africa) records were interrogated for the 
information of all the patients admitted to ICU during the study period. Patient folders and 
laboratory records were examined for the HIV tests results done during and prior to the 
index admission and for patient diagnoses during ICU admission.  
 
1.2.3.1.2 Case definition 
 
Patients were coded as HIV-uninfected if they had a negative HIV test three months prior to 
the index admission, untested if there was no documented HIV test results in the folder or no 
recorded HIV test in the National Health Laboratory Services (NHLS) Electronic records. 
HIV infection was diagnosed by two positive antibody tests. 
 
1.2.3.1.3 Data collection 
 
A standardised form was used to collect demographic information including age, sex, and 
ethnicity. Further, details of length of ICU and hospital stay, use of mechanical ventilation 
and inotropic support were recorded. The most recent CD4 count and HIV viral load, when 
available, were recorded. The Acute Physiology and Chronic Health Evaluation ΙΙ 
(APACHE ΙΙ) score was calculated using laboratory values obtained within 24 hours of ICU 




kidney injury (as defined by Kidney Disease Improving Global Outcomes (KDIGO)) on 
admission to ICU and the use of renal replacement therapy (RRT) were documented (12). 
Diagnoses at ICU admission were categorised by organ system and severity of sepsis (13).  
 
1.2.3.1.4 Statistical analysis  
 
Data analysis was performed using SPSS (version 20, IBM, Armonk, New York, USA). 
Normality of data was tested using the Kolmogorov-Smirnov test. Normally distributed data 
are presented as mean ± standard deviation (SD) or, where highly skewed, as median 
(interquartile range); discrete data are presented as numbers (percentages). The chi-square 
test or Fisher’s exact test was utilised to compare discrete data, as appropriate.  ANOVA 
with post-hoc Bonferroni correction was used to explore whether there were differences 
between the groups. Bivariate correlations were assessed using the Pearson “R” and 
Spearman “RS” coefficients, as appropriate. All statistical tests were two-tailed, with p-
values of less than 0.05 considered significant. 
 
1.2.4 Results  
 
From 1 January 2012 to 31 December 2012, 806 patients were admitted to ICU. Of these, 77 
patients were HIV-infected, giving an incidence of 9.6 per 100 person years, 2 patients were 
younger than 18 years and were excluded in the final analysis (Figure 1). Two hundred and 
thirty seven (29.4%) patients were HIV-uninfected or had tested HIV-negative in the three 
months prior to ICU admission. The HIV status was unknown for 492 (61.%) patients 
admitted to ICU. 
 
1.2.4.1.1 Patient demographic and clinical characteristics at admission to ICU  
 
A total of 75 patients were included in the analysis with a mean age of 36.5 ± 9.6 years 
(Table 1). In keeping with the epidemiology of HIV-infection in SSA, the majority of 
patients were female (64%). CD4 count was available for 74 of the 75 patients. HIV-positive 
patients had a mean (± standard deviation) CD4 count of 293.9×106/L ± 247.2×106/L. HIV 
viral load was available for 27 patients; all these patients were receiving HAART at the time 
of ICU admission.  Thirteen of the 27 patients had a detectable HIV viral load. The median 
HIV viral load was 20,146.5 RNA copies/ml (25thpercentile 372.75 and 75th percentile 
25,898.75).   More than a third of the patients (37.3%) were newly diagnosed with HIV 




Thirty-nine  (52%) patients were not receiving antiretroviral therapy (ART).  The mean 
duration on HAART was 6.3 ± 17.5 months. No patients were started on antiretroviral 
therapy during their ICU stay. Patients that were receiving ART were on HAART. 
 
ICU admission occurred after a median of 2 days (25th percentile 1 and 75th percentile 6) in 
the referring unit; thirty-three (44%) were admitted to ICU within 24 hours of arrival in 
hospital, 17 (22.7%) between 24 to 72 hours and 25 (33.3%) were admitted 72 hours after 
hospital arrival (Figure 2). Thirty-one patients (41.3%) were referred to ICU from the 
general medical wards, 20% from casualty (medical emergency), 16% from the general 
surgical wards, 12% from the trauma ward and 10.7% from maternity (Table 1). 
Approximately one third (30.7%) of the patients were admitted to ICU for respiratory 
illnesses. Fifteen of the patients with respiratory illness had community-acquired pneumonia, 
four had pulmonary tuberculosis (initially referred to ICU as community-acquired 
pneumonia) and the other 4 had Pneumocystis jirovecii pneumonia. The diagnosis of 
Pneumocystis jirovecii pneumonia was made after ICU admission on the basis of a positive 
direct fluorescent antibody test (DFAT) for pneumocystis jirovecii on tracheal aspirates. Two 
of the patients diagnosed with Pneumocystis jirovecii pneumonia had a new diagnosis of 
HIV infection. The other two patients with Pneumocystis jirovecii pneumonia were known to 
be HIV infected and were receiving HAART, their CD4 counts were less than 150 and both 
had a detectable HIV viral load. Ten patients had pulmonary tuberculosis and were receiving 
anti-tuberculosis therapy prior to the admission to ICU. Nineteen patients had previous 
tuberculosis, which had been fully treated.   
 
1.2.4.1.2 Patient clinical characteristics during ICU stay 
 
The majority of patients (90.7%) required mechanical ventilation, and 50.7% required 
inotropic support. Fifty-five (73.3%) patients had acute kidney injury on admission to ICU. 
RRT was offered to 24 patients (32%). Patients presented with a mean APACHE ΙΙ score (± 
standard deviation) of 21.6 ± 8.4.  The median number of days in ICU and in hospital was 4 
(25th percentile 2 75th percentile 8) and 16 (25th percentile 9 75th percentile 34) respectively. 
 
1.2.4.1.3 ICU and in-hospital mortality 
 
Nineteen patients (25.3%) died in ICU, 49 (65.3%) were discharged from hospital alive. Use 
of RRT was significantly associated with in-ICU mortality (OR, 2.2; 95% CI 1.2-4.1; P 




inotropes in ICU was associated with both in-ICU (OR 2.3; 95% CI 1.6-3.4; P <0.001) and 
in-hospital mortality (OR, 2.0; 95% CI 1.4-3.2; p 0.001). An APACHE ΙΙ of more than 13 at 
ICU admission was also significantly associated with increased in-ICU mortality (OR, 1.4; 
95% CI 1.1-1.7; p 0.015) but not in-hospital mortality (OR, 1.3; 95% CI 1.0-1.6; P 0.066).  
The number of days in the referring unit prior to ICU admission did not predict death in ICU 
(p=0.075) or in hospital (p=0.191).  Factors including CD4 count, use of HAART, 
mechanical ventilation, serum albumin and whether the patient is known or newly diagnosed 




The key findings of our study were firstly, respiratory illnesses remain the major indication 
for ICU admission in HIV-infected patients; secondly, there was an in-ICU and in-hospital 
mortality of 25.3% and 34.7% respectively in a South African tertiary hospital setting; 
thirdly, factors associated with poor short-term outcomes in HIV-infected patients admitted 
to ICU were the use of RRT, vasopressor support and an APACHE ΙΙ score of greater than 
13. To our knowledge, this is the first study that determines the outcomes of HIV-infected 
adults admitted to a South African ICU. These results have implications for resource 
allocation and management of HIV-infected patients requiring ICU care in resource-
constrained settings. These results suggest that sicker patients, as suggested by higher 
APACHE ΙΙ, patients requiring organ support such as RRT and inotropes in the setting of 
HIV infection, have worse outcomes. In resource-limited settings, ICU care may have to be 
withheld from HIV-infected patients that meet the above criteria. Further more, these results 
support the general criteria for ICU admission used in the South African public sector, which 
take into account the severity of the clinical presentation and likelihood of ‘reversibility of 
organ dysfunction’ (14). 
 
Intensive care for HIV-infected patients had initially been remarkable for high ICU and 
hospital mortality (15, 16), in keeping with previous reports we report an ICU mortality rate 
of 25.3% (10, 17, 18). Respiratory illnesses remain the leading diagnoses at ICU admission 
in HIV-infected patients (9, 10). It has been reported that mechanical ventilation for 
respiratory illnesses is associated with poor ICU outcomes (9, 19-22). In this South African 
cohort, respiratory illnesses represented the most common indication for ICU, but were not 
associated with increased ICU and hospital death. On the contrary, we also did not find an 
association of mechanical ventilation with ICU and hospital mortality. In a study by Casalino 




(22). In the HAART era, the incidence of Pneumocystis jirovecii pneumonia in HIV-infected 
patients admitted to ICU has decreased to between 3 and 9% (10, 11). Up to 50% of HIV 
infected patients are unaware of HIV status prior to ICU admission (7, 23-25). This patient 
group is characterized by pronounced immunosuppression and typically admitted with 
AIDS-related diagnoses like Pneumocystis jirovecii pneumonia when compared to patients 
that are known to be HIV-infected prior to ICU admission (10, 23, 25-27). The frequency of 
newly diagnosed HIV-infected patients at ICU admission has remained relatively the same in 
the HAART era as in the pre-HAART era, but the frequency of OI’s in ICU has decreased 
(7, 9). In this report, only 5% of the patients had Pneumocystis jirovecii pneumonia. The 
diagnoses of Pneumocystis jirovecii pneumonia was made during their ICU stay. 
Pneumocystis jirovecii pneumonia, the need for mechanical ventilation in Pneumocystis 
jirovecii pneumonia, development of a pneumothorax in Pneumocystis jirovecii pneumonia 
patient and ICU admission for an AIDS-related diagnoses are widely thought to be related to 
high ICU and hospital mortality (8, 17, 19, 24, 28). We do not have information on the 
number of HIV-infected patients that might have qualified for ICU care but were not referred 
to ICU or were turned down for admission. This would help determine the reasons behind 
the denial of ICU care in this patient population and whether the physician attitudes towards 
ICU care for HIV-infected patients have changed. 
 
The severity of the acute event as marked by high APACHE ΙΙ (9, 28-30), the use of 
inotropes (27, 31, 32) and RRT (33) are reported to be associated with poor short-term 
outcomes. In this study we show that a high APACHE ΙΙ score, use of inotropes and RRT to 
be significantly associated with both ICU and hospital mortality in HIV infected patients. 
The presence of these conditions in areas where resource are constrained could be used to 
determine whether ICU admission is warranted or intensive support be initiated. 
 
Between 24 and 50% of HIV infected patients receive HAART prior to ICU admission (8, 
10, 23, 26). Receipt of HAART prior to ICU has been associated with contradictory results 
in terms of association with short-term outcomes. Some authors have reported increased 
survival rates in patients on HAART prior to ICU admission and others have reported that 
receipt of HAART did not predict short-term outcomes (7, 8, 11, 27). In this study, 48% of 
the patients were on HAART prior to ICU admission, HAART prior to ICU admission did 
not predict ICU and hospital survival.  Reports have shown that HIV viral load and CD4 
count did not predict ICU and hospital survival (11, 27, 28).  Similarly, in our study, we did 
not find any statistically significant association between detectable HIV viral load, low CD4 





Up to 50% of HIV-infected persons have severe sepsis at ICU admission, or suffer from 
severe sepsis during their ICU stay (32). Many infections responsible for sepsis in this 
patient population are nosocomial, followed by AIDS-related infections (29). Ward stay 
prior to ICU admission is a risk factor to for sepsis in HIV-infected patient (32). Severe 
sepsis has been reported to be associated with poor ICU outcomes in HIV-infected patients 
(32). In this study, 13.3% of the patient had the diagnoses of severe sepsis at ICU admission, 
42% acquired severe sepsis during their ICU stay. We did not find an association between 
severe sepsis and death in this cohort.  
 
The fact that 52% of the patients in this cohort were not receiving HAART, and 18.7% had a 
detectable HIV viral load while receiving HAART, suggests that improving ICU care plays a 
major role in the better outcomes of HIV-infected patient in ICU (In our hospital, we have 
adopted lung protective ventilation, surviving sepsis guidelines and appropriate glucose 
control in our ICU (34, 35)). There were very few case of Pneumocystis jirovecii pneumonia, 
this might account for the apparent lack of association between respiratory illnesses, 
mechanical ventilation and death. 
 
Our study has several important limitations. Firstly it is a single centre study. Secondly, the 
study suffers from the limitations and biases of its retrospective nature. Thirdly, we were not 
able to find and document the microbiological causes of all the cases of community-acquired 
pneumonia, which could offer an opportunity for prophylaxis. Fourthly and most 
importantly, 61% of our ICU population did not have an HIV test, considering that our 
community has a high prevalence of HIV infection this may presents a missed opportunity in 
testing and potential treatment.   
 
This study shows that critical care outcomes for HIV-infected patients at Groote Schuur 
Hospital are comparable to those in the developed world. This study presents findings from a 
tertiary care unit, this findings are not representative of the rest of country.  It highlights that 
ICU outcomes for this patient population depend on the severity of the acute illness 
irrespective of the receipt of HAART and the immune status. More research is needed that is 









1.2.6 Figures and tables  
1.2.6.1.1 Figure 1: Flow diagram demonstrating patient enrolment.  ICU denotes intensive 
care unit, HIV denotes Human Immunodeficiency Virus. 
 
 

























Characteristic  Number  
N=75 
Age (years)¶ 36.5 ±9.6 
Female (%) 64 
Race (%)  
        Black   84 
        Mixed race  16 
Newly diagnosed HIV (%) 37.3 
On HAART (%) 48 
Duration on HAART (months) 0-72 range 
CD4 count  (×106/L) ¶ 293.9 ±247.2 
Detectable HIV viral load (%)  18.7 
Prior HIV related illnesses (%)  
        Tuberculosis  25.3 
        Syphilis  1.3 
        HIV associated nephropathy  1.3 
Source of Referral (%)  
        Emergency unit¥  32 
        Medical ward 41.3 
        Surgical ward 16 
        Maternity  10.7 
Number of days in the referring unit# 2 (1 and 45) 
Diagnoses at ICU admission (%)  
       Respiratory illness 30.7 
       Severe sepsis 13.3 
       Trauma  12 
       Drug toxicity and poisoning  8 
       Neurological illness 9.3 
       Elective surgery 8 
       Other*  18.7 
APACHE ΙΙ ¶ 21.6 ± 8.4 
AKI on admission (%) 26.7 
Mechanical ventilation (%) 90.7 
Renal replacement therapy (%) 32 
Inotropic support (%) 50.7 
ICU Complications (%)  
       AKI 16 
       Sepsis 25.3 
       AKI and sepsis 17.3 
Number of days in ICU# 4 (2 and 8) 
Number of days in Hospital# 16(9 and 34) 
  
¶Mean ± SD  
*Included patient admitted with renal illness, malaria, 
gastrointestinal illness, emergency surgery and cardiac illness. 
#Median (interquartile range) 






























Odds ratio  
(95% CI) 
P value Death 
in 
hospital  




       
Female (n=48) 15 1.2 (0.8-1.7) 0.403 16 0.9 (0.7-1.4) 0.746 
Respiratory illnesses  (n=23) 6 1.1 (0.5-2.3) 0.755 7 1.8 (0.4-1.7) 0.609 
Severe Sepsis (n=10) 3 1.1 (0.3-3.9) 0.880 6 2.8 (0.9- 9.1) 0.071 
AKI on admission  (n=20) 7 1.7 (0.8-3.6) 0.163 8 1.3 (0.6-2.7) 0.558 
Mechanical ventilation (n=68) 20 1.0 (0.9-1.2) 0.396 25 1.1 (1.0-1.2) 0.234 
Renal replacement therapy 
(n=24) 
11 2.2 (1.2-4.1) 0.018 12 1.9 (1.0-3.6) 0.056 
Inotropic support (n=38) 18 2.3 (1.6-3.4) <0.001 20 2.0 (1.4-3.2) 0.001 
APACHE ΙΙ >13 (n=57) 20 1.4 (1.1-1.7.) 0.015 23 1.3 (1.0-1.6) 0.066 
Newly diagnosed HIV (n=28) 10 1.4 (0.8-2.6) 0.251 11 1.2 (0.7-2.2) 0.516 
Not on HAART (n=39) 13 1.3 (0.8-2.0) 0.284 16 1.3 (0.9-2.0) 0.228 
Detectable HIV viral load 
(n=13) 
4 1.3 (0.6-2.8) 0.580 5 1.3 (0.6-2.7) 0.586 
CD4 count < 200 (n=35) 12 1.4 (0.9-2.3) 0.183 15 1.5 (0.9-2.3) 0.118 
Duration in the referring unit   0.075   0.191 
Less than 24 hours 
(n=33) 
9   12   
24 to 72 hours  (n=17) 1   3   
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